1
|
Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis.
|
Cell
|
2007
|
8.84
|
2
|
HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers.
|
Cell
|
2012
|
2.94
|
3
|
Tight coordination of protein translation and HSF1 activation supports the anabolic malignant state.
|
Science
|
2013
|
2.79
|
4
|
17AAG: low target binding affinity and potent cell activity--finding an explanation.
|
Mol Cancer Ther
|
2003
|
2.74
|
5
|
Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease.
|
Proc Natl Acad Sci U S A
|
2009
|
2.35
|
6
|
Altered Hsp90 function in cancer: a unique therapeutic opportunity.
|
Mol Cancer Ther
|
2004
|
2.16
|
7
|
High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer.
|
Proc Natl Acad Sci U S A
|
2011
|
2.03
|
8
|
Fitness trade-offs restrict the evolution of resistance to amphotericin B.
|
PLoS Biol
|
2013
|
1.88
|
9
|
Phase I pharmacokinetic and pharmacodynamic study of 17-N-allylamino-17-demethoxygeldanamycin in pediatric patients with recurrent or refractory solid tumors: a pediatric oncology experimental therapeutics investigators consortium study.
|
Clin Cancer Res
|
2007
|
1.80
|
10
|
Hsp90: an emerging target for breast cancer therapy.
|
Anticancer Drugs
|
2004
|
1.64
|
11
|
A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group study.
|
Clin Cancer Res
|
2007
|
1.61
|
12
|
Actin microfilament aggregation induced by withaferin A is mediated by annexin II.
|
Nat Chem Biol
|
2005
|
1.55
|
13
|
Chaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells.
|
Nat Biotechnol
|
2013
|
1.33
|
14
|
Using the heat-shock response to discover anticancer compounds that target protein homeostasis.
|
ACS Chem Biol
|
2011
|
1.31
|
15
|
Loss of tumor suppressor NF1 activates HSF1 to promote carcinogenesis.
|
J Clin Invest
|
2012
|
1.25
|
16
|
Search for Hsp90 inhibitors with potential anticancer activity: isolation and SAR studies of radicicol and monocillin I from two plant-associated fungi of the Sonoran desert.
|
J Nat Prod
|
2006
|
1.20
|
17
|
Hormone-refractory breast cancer remains sensitive to the antitumor activity of heat shock protein 90 inhibitors.
|
Clin Cancer Res
|
2003
|
1.12
|
18
|
2,3-Dihydrowithaferin A-3beta-O-sulfate, a new potential prodrug of withaferin A from aeroponically grown Withania somnifera.
|
Bioorg Med Chem
|
2008
|
1.12
|
19
|
A rhizosphere fungus enhances Arabidopsis thermotolerance through production of an HSP90 inhibitor.
|
Plant Physiol
|
2007
|
1.11
|
20
|
Heat shock protein 90: a unique chemotherapeutic target.
|
Semin Oncol
|
2006
|
1.06
|
21
|
Hsp90 is essential in the filarial nematode Brugia pahangi.
|
Int J Parasitol
|
2005
|
1.05
|
22
|
Cytotoxic constituents of Aspergillus terreus from the rhizosphere of Opuntia versicolor of the Sonoran Desert.
|
J Nat Prod
|
2003
|
1.01
|
23
|
Hsp90 inhibitors deplete key anti-apoptotic proteins in pediatric solid tumor cells and demonstrate synergistic anticancer activity with cisplatin.
|
Int J Cancer
|
2005
|
1.00
|
24
|
Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens, a constituent of the herbal supplement PC SPES.
|
J Nat Prod
|
2004
|
0.99
|
25
|
Two cases of pediatric neuroblastoma with tumor thrombus in the inferior vena cava.
|
J Pediatr Hematol Oncol
|
2002
|
0.98
|
26
|
Inhibiting GPI anchor biosynthesis in fungi stresses the endoplasmic reticulum and enhances immunogenicity.
|
ACS Chem Biol
|
2012
|
0.98
|
27
|
Geopyxins A-E, ent-kaurane diterpenoids from endolichenic fungal strains Geopyxis aff. majalis and Geopyxis sp. AZ0066: structure-activity relationships of geopyxins and their analogues.
|
J Nat Prod
|
2012
|
0.96
|
28
|
Expression of a unique drug-resistant Hsp90 ortholog by the nematode Caenorhabditis elegans.
|
Cell Stress Chaperones
|
2003
|
0.92
|
29
|
HSP90: a rising star on the horizon of anticancer targets.
|
Future Oncol
|
2005
|
0.92
|
30
|
The anticancer activity of the fungal metabolite terrecyclic acid A is associated with modulation of multiple cellular stress response pathways.
|
Mol Cancer Ther
|
2005
|
0.91
|
31
|
Isolation, optimization of production and structure-activity relationship studies of monocillin I, the cytotoxic constituent of Paraphaeosphaeria quadriseptata.
|
J Antibiot (Tokyo)
|
2004
|
0.90
|
32
|
Structure-activity relationships for withanolides as inducers of the cellular heat-shock response.
|
J Med Chem
|
2014
|
0.88
|
33
|
Piperazinyl quinolines as chemosensitizers to increase fluconazole susceptibility of Candida albicans clinical isolates.
|
Bioorg Med Chem Lett
|
2011
|
0.87
|
34
|
A new dihydroxanthenone from a plant-associated strain of the fungus Chaetomium globosum demonstrates anticancer activity.
|
Bioorg Med Chem
|
2006
|
0.87
|
35
|
Autoantibodies to villin occur frequently in IPEX, a severe immune dysregulation, syndrome caused by mutation of FOXP3.
|
Clin Immunol
|
2011
|
0.87
|
36
|
Overcoming fluconazole resistance in Candida albicans clinical isolates with tetracyclic indoles.
|
Bioorg Med Chem Lett
|
2012
|
0.85
|
37
|
Evidence for a Novel, Caspase-8-Independent, Fas Death Domain-Mediated Apoptotic Pathway.
|
J Biomed Biotechnol
|
2004
|
0.81
|
38
|
Biomimetic kinetic resolution: highly enantio- and diastereoselective transfer hydrogenation of aglain ketones to access flavagline natural products.
|
J Am Chem Soc
|
2014
|
0.81
|
39
|
ML212: A small-molecule probe for investigating fluconazole resistance mechanisms in Candida albicans.
|
Beilstein J Org Chem
|
2013
|
0.81
|
40
|
Design of quinolinedione-based geldanamycin analogues.
|
Bioorg Med Chem Lett
|
2003
|
0.76
|
41
|
Synthesis and biological evaluation of novobiocin analogues as potential heat shock protein 90 inhibitors.
|
Bioorg Med Chem
|
2013
|
0.76
|
42
|
Preface.
|
Adv Cancer Res
|
2016
|
0.75
|